Medical/Pharmaceuticals
US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG
SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalis...
2020-08-07 08:30
14085
CMAB Appoints Ms. Maggie Chen as Chief Financial Officer
SUZHOU, China, Aug. 6, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Ms.Maggie Chen as the chief financial officer. Ms. Chen will lay a solid foundation for the long-...
2020-08-07 08:00
4620
Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment, Acquires IP From World Leader in Respiratory Disease Medicine
Technology, expertise from UK's Mucokinetica to accelerate repurposing of generic remedy nafamostat for COVID-19 oral, inhalation therapy SAN DIEGO, Aug. 7, 2020 /PRNewswire/ -- A biopharmaceutical company repurposing nafamostat, a generic remedy for pancreatitis and acute kidney injury, is one ...
2020-08-07 01:30
3996
Dietary cholesterol and phytosterols contribute directly to heart disease
Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk REYKJAVIK, Iceland, Aug. 7, 2020 /PRNewswire/ -- Scientists at deCODE genetics , a subsidiary of Amgen, and their collaborators fromthe Icelandic healthcare system, University of Iceland, the Copenha...
2020-08-07 01:21
5653
ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies
SHENZHEN and SHANGHAI, August 6, 2020 /PRNewswire/ -- ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd today announced a clinical collaboration and exclusive license agreement for ImmVira's MVR-T3011 intratumoral oncolytic virus program for the commercialization of novel immun...
2020-08-06 23:49
9556
The 23rd TDO® Software and 2nd GentleWave® User Meeting Moving to an All Virtual Experience
LAGUNA HILLS, California, Aug. 6, 2020 /PRNewswire/ -- Sonendo, Inc., a leading dental technology company, developer of theGentleWave System and the parent company of TDO Software Inc., the leading endodontic practice management software developer, announced today that its Annual TDO and GentleWa...
2020-08-06 20:32
3658
I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020
SHANGHAI and GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will report financial results for the six months ...
2020-08-06 20:30
14839
Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development
Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer gl...
2020-08-06 20:10
2828
Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma
SINGAPORE, Aug. 6, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a
clinical-stage cell therapy company developing next-generation cancer
treatments, today announced the publication of results in theJournal of
Clinical Oncology
2020-08-06 19:00
3103
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer
SHANGHAI and DUNDALK, Ireland, Aug. 6, 2020 /PRNewswire/ -- WuXi Vaccines, a global leading company with world-class vaccine contract development and manufacturing organization (CDMO) capabilities, is pleased to announce the appointment of Mr.Jian Dong as Chief Executive Officer (CEO). WuXi Vacci...
2020-08-06 17:00
3217
Nolato acquires US-based medtech manufacturer with annual sales of approximately SEK 1.8 billion
TOREKOV, Sweden, Aug. 6, 2020 /PRNewswire/ -- Nolato has signed an agreement to acquire US-based GW Plastics. The company, which was founded in 1955, has annual sales of approximatelySEK 1.8 billion and an EBITA margin of around 7%. The acquisition price, including contingent consideration, is es...
2020-08-06 13:34
12450
FDA issues Emergency Use Authorization to Vela Diagnostics' coronavirus PCR test
FAIRFIELD, N.J., Aug. 6, 2020 /PRNewswire/ -- Vela Diagnostics announced that the manual version of its coronavirus PCR test has obtained Emergency Use Authorization from the U.S. Food and Drug Administration (FDA). By targeting conserved regions of the viral genome, the probe-based reverse trans...
2020-08-06 11:42
3495
New Rapid Cardiac MR Imaging Helps Detect and Manage Patient Heart Health During and After Cancer Treatments
HOUSTON, Aug. 5, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, along with Myocardial Solutions, a medical technology company working to transform the cardiac and cancer care continuum, announced today FDA premarket clearance to market...
2020-08-06 00:00
2115
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
NEW BRUNSWICK, New Jersey, Aug. 5, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses...
2020-08-05 20:30
6809
Samsung Biologics launches S-CHOice cell line expression technology
INCHEON, South Korea, Aug. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX:
207940.KS) today held an online ceremony to announce the launch of its
proprietary cell line technology, S-CHOice.
2020-08-05 09:09
2928
COVID-19 and heightened attention to racism affect Australian workers' mental health and relationships
Morneau Shepell's Mental Health Index™ remains steady in July at 12 points below the pre-pandemic benchmark of 75 MELBOURNE, Australia, Aug. 5, 2020 /PRNewswire/ -- Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today released its month...
2020-08-05 06:00
2182
Colorcon Opens New Technical Centre in Melbourne, Australia to support the growing local pharmaceutical industry
HARLEYSVILLE, Penn., Aug. 5, 2020 /PRNewswire/ -- Colorcon, a world leader in the development and supply of film coating systems and excipients, today announces the opening of a new technical center inMelbourne, Australia. The facility provides customers in Australasia access to pharmaceutical cl...
2020-08-05 05:00
3469
China NMPA Accepts IND Application for Eftansomatropin Pivotal Trial in Pediatric Patients with Growth Hormone Deficiency
SHANGHAI and GAITHERSBERG, Md., Aug. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the China National Medical Products Administration (...
2020-08-04 20:17
15875
World Federation of Hemophilia (WFH) publishes "The WFH Guidelines for the Management of Hemophilia, 3rd edition"
MONTREAL, Aug. 4, 2020 /PRNewswire/ -- Led by content leads, Alok Srivastava, MD, andGlenn Pierce, MD, PhD, WFH Vice-President, Medical, this 3rd edition of the World Federation of Hemophilia (WFH) Guidelines for the Management of Hemophilia offers up-to-date guidance and practical recommendation...
2020-08-04 17:00
2426
Adagio Medical, Inc., reports pre-clinical effectiveness combining their existing ultra-low temperature cryoablation catheter with Pulsed Field Ablation (PFA) in a single Pulsed Field Cryoablation (PFCA) catheter
LAGUNA HILLS, California, Aug. 4, 2020 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of theintelligent Continuous Lesion Ablation System (iCLAS™), today announced successful pre-clinical re...
2020-08-04 10:16
2933
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8546
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7700